Our future research will adopt a multicenter collaborative approach with expanded enrollment to systematically validate the prognostic value of positive lymph node ratio (pLNR) and HER-2 status in guiding adjuvant chemoradiotherapy for locally advanced gastric cancer. The gene discussed is ERBB2; the disease is gastric cancer.